Brind.

A company presented data on using Actinium-225 in radiotherapy at the European Association of Nuclear Medicine congress in Vienna, Austria.

1 report, 1 independent Updated 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

A company presented data on using Actinium-225 in radiotherapy at the European Association of Nuclear Medicine congress in Vienna, Austria.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped